Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.39 by 23.08 percent. This is a 23.08 percent increase over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $194.255 million which beat the analyst consensus estimate of $192.279 million by 1.03 percent. This is a 14.83 percent increase over sales of $169.172 million the same period last year.